论文部分内容阅读
反流性食管炎(RE)是由多种因素引起的酸相关性疾病,与胃酸、胃蛋白酶、胆汁反流及食管下端括约肌功能障碍、食管廓清能力降低等密切相关,临床单纯抑酸或单纯促动力治疗效果欠佳。我们采用新型质子泵抑制剂泮托拉唑与胃动力药多潘立酮联合治疗反流性食管炎,并与单独使用泮托拉唑治疗反流性食管炎进行比较,对其综合疗效进行评价。
Reflux esophagitis (RE) is caused by a variety of factors, acid-related diseases, and gastric acid, pepsin, bile reflux and lower esophageal sphincter dysfunction, esophageal clearance is reduced and so is closely related to the clinical simple acid or simple Motivation treatment ineffective. We used a new proton pump inhibitor pantoprazole and gastric motor drug domperidone in the treatment of reflux esophagitis and pantoprazole alone with the treatment of reflux esophagitis compared to evaluate its comprehensive efficacy.